Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

See our complete portfolio of awards below.

View Funded Institutions
View Funded Investigators
Find Clinical Trials

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Scripps Research Institute Luke L Lairson Quest – Discovery Stage Research Projects Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs $1,554,126
University of California, San Francisco Dr Julia Carnevale Quest – Discovery Stage Research Projects Generating deeper and more durable BCMA CAR T cell responses in Multiple Myeloma through non-viral knockin/knockout multiplexed genome engineering $1,463,368
Stanford University Sarah Heilshorn Quest – Discovery Stage Research Projects Injectable, autologous iPSC-based therapy for spinal cord injury $789,000
Navega Therapeutics Ana Maria Moreno Quest – Discovery Stage Research Projects Optimization of a gene therapy for inherited erythromelalgia in iPSC-derived neurons $1,157,313
Cedars-Sinai Medical Center Eduardo Marbán Quest – Discovery Stage Research Projects New noncoding RNA chemical entity for heart failure with preserved ejection fraction. $1,397,412
Stanford University Dr. Stanley Qi Quest – Discovery Stage Research Projects A novel hybrid CRISPR tool for gene network perturbation and hiPSC engineering $704,630
University of California, San Diego Ziwei Huang Quest – Discovery Stage Research Projects Development of a new therapeutic for directing target specific stem cell migration and treatment $1,129,512
University of California, San Diego Dan S Kaufman Quest – Discovery Stage Research Projects Human iPSC-derived chimeric antigen receptor expressing macrophages for improved cancer treatment. $1,256,332
Stanford University Dr. Marius Wernig MD, PhD Quest – Discovery Stage Research Projects A universally applicable skin sheet for Dystrophic Epidermolysis Bullosa via next-generation gene editing, iPS cell technology and tissue engineering $1,229,040
University of California, Davis Dr. David J Segal PhD Quest – Discovery Stage Research Projects AAV9-Cas13 gene therapy for Angelman syndrome $1,364,903
Stanford University Dr. Phillip C Yang Quest – Discovery Stage Research Projects Hypoxia-specific Production of Exosomes from iPSC-derivatives for Myocardial Repair $1,418,023
Stanford University Kathleen M Sakamoto Quest – Discovery Stage Research Projects Small Molecules to inhibit Nemo-like Kinase for Treatment of Diamond Blackfan Anemia $846,638
University of California, Irvine Munjal M Acharya Quest – Discovery Stage Research Projects Stem cell-derived extracellular vesicles to reverse radiation-induced brain injury $1,064,108
University of California, San Francisco Dr Marisa Medina Quest – Discovery Stage Research Projects iPSCs as a screening tool to predict risk of nonalcoholic fatty liver disease $813,000
University of California, San Diego Tannishtha Reya Quest – Discovery Stage Research Projects Targeting Critical Regulators of Cancer Stem Cells $1,148,264
University of California, Davis Dr. Deborah K Lieu Quest – Discovery Stage Research Projects Building a hiPSC-based biopacemaker $1,260,827
City of Hope, Beckman Research Institute Dr. Yanhong Shi Quest – Discovery Stage Research Projects Combating COVID-19 using human PSC-derived NK cells $249,998
University of California, San Diego Tariq M Rana Quest – Discovery Stage Research Projects Development of COVID-19 Antiviral Therapy Using Human iPSC-Derived Lung Organoids $250,000
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Disease Team Therapy Planning I Stem Cells Secreting GDNF for the Treatment of ALS $63,487
University of California, San Diego Armin Blesch Progression Award – Discovery Stage Research Projects Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury $180,000
Stanford University Dr. Helen M Blau Progression Award – Discovery Stage Research Projects Stimulating endogenous muscle stem cells to counter muscle wasting $237,060
University of California, Irvine Dr. Brian J. Cummings Progression Award – Discovery Stage Research Projects Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI) $202,667
University of California, Berkeley Kevin E. Healy Progression Award – Discovery Stage Research Projects Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy $224,500
University of California, Los Angeles Dr. Caroline Y. Kuo Progression Award – Discovery Stage Research Projects Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 $234,000
Neurona Therapeutics Dr. Cory R Nicholas Progression Award – Discovery Stage Research Projects Global gene expression profiling of single inhibitory neurons derived from human stem cells $202,500
Stanford University Professor Hiromitsu Nakauchi Progression Award – Discovery Stage Research Projects Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells $208,422
Aspen Neuroscience Dr. Andres Bratt-Leal Progression Award – Discovery Stage Research Projects Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells $177,579
1 … 23 24 25 26 27 28 29 30 31 32 33